KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Dividends payables (2016 - 2025)

Pfizer has reported Dividends payables over the past 17 years, most recently at $2.4 billion for Q4 2025.

  • Quarterly Dividends payables changed 0.33% to $2.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 billion through Dec 2025, changed 0.33% year-over-year, with the annual reading at $2.4 billion for FY2025, 0.33% changed from the prior year.
  • Dividends payables was $2.4 billion for Q4 2025 at Pfizer, roughly flat from $2.4 billion in the prior quarter.
  • Over five years, Dividends payables peaked at $2.4 billion in Q2 2025 and troughed at $2.2 billion in Q3 2021.
  • The 5-year median for Dividends payables is $2.3 billion (2022), against an average of $2.3 billion.
  • Year-over-year, Dividends payables increased 4.02% in 2021 and then increased 0.33% in 2025.
  • A 5-year view of Dividends payables shows it stood at $2.2 billion in 2021, then rose by 2.4% to $2.3 billion in 2022, then increased by 3.0% to $2.4 billion in 2023, then increased by 2.74% to $2.4 billion in 2024, then rose by 0.33% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Dividends payables are $2.4 billion (Q4 2025), $2.4 billion (Q2 2025), and $2.4 billion (Q4 2024).